C. BİLİR Et Al. , "Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain," Journal of Human Rhythm , vol.2, no.2, pp.78-82, 2016
BİLİR, C. Et Al. 2016. Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain. Journal of Human Rhythm , vol.2, no.2 , 78-82.
BİLİR, C., BALIK, M. S., kızılkaya, b., YILDIRIM, Ş., görmez, s., & bilir, f., (2016). Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain. Journal of Human Rhythm , vol.2, no.2, 78-82.
BİLİR, CEMİL Et Al. "Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain," Journal of Human Rhythm , vol.2, no.2, 78-82, 2016
BİLİR, CEMİL Et Al. "Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain." Journal of Human Rhythm , vol.2, no.2, pp.78-82, 2016
BİLİR, C. Et Al. (2016) . "Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain." Journal of Human Rhythm , vol.2, no.2, pp.78-82.
@article{article, author={CEMİL BİLİR Et Al. }, title={Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain}, journal={Journal of Human Rhythm}, year=2016, pages={78-82} }